Ryan P Taylor

Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)

J. Crawford, R. Gralla, J. Dalton, 2016, Current Oncology Reports.

Small heat shock proteins: a new classification scheme in mammals.

I. Benjamin, Ivor J Benjamin, Ryan P Taylor, 2005, Journal of molecular and cellular cardiology.